BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 12574769)

  • 1. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyroid cancers].
    Mogoş V; Zbranca E; Strat V; Diaconescu MR; Chifan M; Florea N; Costăchescu G; Găleşanu MR; Rusu V; Georgescu G
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):72-81. PubMed ID: 9524659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based outcomes for pediatric thyroid carcinoma.
    Shapiro NL; Bhattacharyya N
    Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
    Zaydfudim V; Feurer ID; Griffin MR; Phay JE
    Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between the pathological characteristics and the prognosis of thyroid carcinoma].
    Liu FS
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):381-4. PubMed ID: 8174487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
    Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
    Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in well-differentiated thyroid carcinoma.
    Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and validation of prognostic factors in differentiated thyroid carcinoma].
    Gómez Arnaiz N; Gómez Sáez IM; Sahún de la Vega M; Abós R; Villabona Artero C; Soler Ramón J
    Med Clin (Barc); 1997 Jan; 108(2):45-9. PubMed ID: 9064416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of differentiated thyroid gland carcinoma].
    Walgenbach S; Sternheim E; Bittinger F; Junginger T
    Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
    Hughes CJ; Shaha AR; Shah JP; Loree TR
    Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.